联合阻断IL-25、IL-33和TSLP在哮喘小鼠模型中增强抑制气道炎症与重塑
该研究在卵清蛋白诱导的小鼠哮喘模型中,比较了IL-33受体基因缺失(St2-/-)基础上额外单用或联合抗IL-25和抗TSLP阻断抗体的效果。结果显示联合阻断三种细胞因子可进一步显著减轻炎症、Th2细胞因子表达、气道纤维化和IgE产生,提示联合阻断可能更好改善气道病理改变。
要点
- 在St2-/-小鼠中,联合抗IL-25和抗TSLP抗体进一步显著减轻炎症、Th2细胞因子、纤维化和IgE。
- 单用抗TSLP抗体可减少嗜酸性粒细胞浸润和局部IL-4表达。
- 同型对照抗体也可减少气道炎症细胞浸润和Th2细胞因子表达,但不减少纤维化相关蛋白。
核心结论
- 联合阻断IL-25、IL-33和TSLP可能更好改善该小鼠哮喘模型的气道病理改变,对人类哮喘有提示意义。
研究设计与样本
- 小鼠哮喘模型采用卵清蛋白致敏和激发,对照为生理盐水。
- 比较同品系野生型与IL-33受体基因缺失(St2-/-)小鼠。
- 在St2-/-小鼠中再给予抗IL-25和/或抗TSLP阻断抗体。
主要发现
- St2-/-基因缺失显著降低卵清蛋白致敏和激发后的气道反应性、炎症细胞浸润、肺组织Th2细胞因子和纤维化相关蛋白表达及血清总IgE。
- 在St2-/-小鼠中额外给予抗IL-25和抗TSLP抗体进一步显著减少炎症、Th2细胞因子表达、气道纤维化和IgE产生。
- 单用抗TSLP抗体减少嗜酸性粒细胞浸润和局部IL-4表达。
- 同型对照抗体也可减少气道炎症细胞浸润和肺组织Th2细胞因子表达,但不减少纤维化相关蛋白。
临床怎么用
- 该结果为小鼠模型证据,提示联合靶向IL-25、IL-33和TSLP可能增强抑制哮喘气道炎症与重塑。
- 尚需人体研究验证联合阻断策略的疗效与安全性。
局限性
- 研究为小鼠哮喘模型,结果不能直接外推至人类哮喘。
- 同型对照抗体也影响部分炎症指标,提示存在非特异性效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Isolated blockade of IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) has been shown to reduce airways inflammation and hyperresponsiveness in murine asthma model. The hypothesis that combined blockade of all three cytokines can accomplish this more effectively has never been addressed. METHODS: We studied a murine asthma model employing sensitization and challenge with ovalbumin (OVA) or saline control. To discern the effects of IL-33 blockade, we compared outcomes in strain identical, wild-type and IL-33 receptor (St2 -/- ) gene-deleted mice. We then examined, in the St2 -/- animals, the effects of additional, single or combined blockade of IL-25 and TSLP with blocking antibodies. Outcomes included airways reactivity, inflammatory cellular infiltration, epithelial cell metaplasia, deposition of fibrosis-related proteins, local Th2-type cytokine expression and total and specific serum IgE concentrations measured by ELISA and quantitative immunohistochemistry. RESULTS: St2 -/- gene deletion significantly reduced airways reactivity, inflammatory cellular infiltration, lung tissue expression of Th2 cytokines and fibrosis related proteins and serum total IgE in response to OVA sensitization and challenge. Additional administration of anti-IL-25 and anti-TSLP blocking antibodies to the St2 -/- mice further significantly reduced inflammation, Th2 cytokine expression, airways fibrosis and IgE production, while anti-TSLP alone reduced eosinophil infiltration and local IL-4 expression. The airways inflammatory cellular infiltrate and lung tissue expression of Th2 cytokine, but not fibrosis-related proteins were also reduced in the presence of isotype identical, control antibodies. CONCLUSION: Combined blockade of these three cytokines may better ameliorate airways pathological changes in this murine asthma model, with implications for human asthma.
引用
- An G, Wang W, Zhang X, et al. Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma. Respirology. 2019. PMID: 31610614. doi:10.1111/resp.13711
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。